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Abstract: ERP is common abbreviation for event-related brain potentials, which 
are measured and used in clinical practice as well as in research practice. 
Contemporary studies of placebo effect are often based on functional neuro-
magnetic resonance (fMRI), positron emission tomography (PET), and event 
related potentials (ERP). This paper considers an ERP instrumentation system 
used in experimental researches of placebo effect. This instrumentation system 
can be divided into four modules: electrodes and cables, conditioning module, 
digital measurement module, and PC module for stimulations, presentations, 
acquisition and data processing. The experimental oddball paradigm is supported 
by the software of the instrumentation. 
Keywords: Biomedical measurements, Electroencephalography, Event-related 
potentials, Cognitive neuroscience, Placebo. 
1 Introduction 
Electroencephalography (EEG) is a neuro-physiological method frequently 
used in diagnostics for detecting neuro-physiological disorders of central 
nervous system (CNS). This method is based on measurement of variations of 
brain electrical activities. EEG signals are non-stationary and oscillatory 
signals, and their magnitudes are less than 300uV[1]. EEG signal frequency 
bands are usually divided into five areas: delta (0.5-4 Hz), theta (4-8 Hz), alpha 
(8-12 Hz), beta (12-30 Hz) and gamma (≥30 Hz). 
ERP is common abbreviation for event-related brain potentials. During the 
first researches of this potentials, only phenomena of specific electrical 
activities evoked by a stimulus were observed. These phenomena were named 
evoked potentials (EP), thus making distinction from spontaneous electrical 
activities of brain (the ones not evoked by external stimuli – and called just 
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EEG potentials). After that, in 1969 Herb Vaughan used the name event-related 
potentials (ERP) for brain electrical activities he observed during intended 
movements and other psychological processes relatively independent from 
stimuli [2]. 
Nowadays, evoked potentials are standard diagnostic method in clinical 
tests and they are evoked by visual, audio, magnetic or electrical stimulation of 
sensory or motor pathways. This method procedures enables detection of 
defects in neural pathways before appearance of clinical signs of defects. For 
example, it is possible to detect defects of eye neural pathways before eyesight 
weakening or before changes at rear part of eye, analyzing records of visual 
evoked potentials. 
Some of ERPs (P100, N100, P200, N200 and P300), which occur during 
simple tasks performed by subject, are used for detecting cognitive functions of 
respondents. Individual factors which influence parameters of the measured 
ERP include respondent age, awakeness level and active attention. Important 
factors for clinical application of ERP measurements in clinical conditions are 
stability and repeatability of recorded parameters.  
Recent researches are often directed towards the application of ERP in 
Brain Computer Interface (BCI) systems which provide paralytic patients with 
basic communication capabilities so that they can communicate their intends to 
caregivers, operate switches, operate word processing programs, and move 
artificial limbs [3 – 5]. Also, ERP measurements found to be very useful for 
improving technological concepts intended for human-machine interaction [6]. 
Generally, it is very difficult to detect accurate record of ERP after 
presenting only one stimulus, because ERP is superposed with spontaneous 
EEG potential which has enough high intensity to cover ERP. The method for 
achieving accurate ERP record is based on presentation of many individual 
stimuli (tens or hundreds) followed by recording individual potential records, 
and finally ended by averaging all the individual records which results in more 
accurate measurement. This method rejects spontaneous EEG potentials, 
enabling clear extraction of ERP, and it is still most frequently used in practice, 
although there are new researches on alternative methods (so called parametric 
methods) based on one stimulus presentation. [7 – 8] 
Scientific interest in the nature and mechanisms of placebo effects started 
1955 with Henry Beecher and his influential paper “The powerful placebo” [9]. 
During 1978 Levine, Gordon and Fields demonstrated that the opioid antagonist 
naloxone could block placebo painkillers, suggesting that endogenous opioids 
are involved, and after that, there was no doubt that placebo effect has 
neurobiological base [10]. A serious of studies of placebo based on functional 
neuro-magnetic resonance (fMRI), positron emission tomography (PET), and 
event related potentials (ERP) are performed [11 – 14]. Measurement of Event-related Potentials and Placebo 
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Continuing from [11  –  14] new researches of placebo effect, based on 
measurements of ERP, are performed in Laboratory of experimental psychology 
Novi Sad [15]. Those new researches were to answer the two questions. First 
question was: “Are there ERP components which are correlates of placebo 
effect when respondents are stimulated by thermal stimuli?”. Second question 
was: “Are there ERP components which are correlates of anti-placebo effect 
when respondents are stimulated by thermal stimuli?” Answer on first question 
was positive and it gave a new confirmation of correlation between ERP and 
placebo. Answer on second question is still being formulated by current 
researches, but regardless of the final answer, this is the first research of 
correlation between ERP and anti-placebo effects. 
This paper considers an ERP instrumentation system used during the 
ERP/placebo researches from [15]. To best knowledge of the authors, this is the 
first one-PC based ERP instrumentation system designed for ERP/placebo 
experiments, and the first ERP instrumentation system with thermal stimuli 
module integrated with PC. This novel system is designed according to specific 
requirements formulated after analyzing plan of the ERP/placebo researches. 
2 Instrumentation 
The instrumentation system can be divided into four blocks (Fig. 1). First 
block is consisted of cables and electrodes connected to respondent. Electrodes 
are Ag/AgCl (silver/silver/chloride) surface disk electrodes (9 mm diameter), 
because this type of electrodes have relatively low impedance and stable offset 
potential. Cables are shielded and its shield is connected to virtual ground of 
amplifier circuit, for this techniques reduce capacitive and inductive coupling of 
cables with the environmental electrical installations. The cables are not longer 
then 120cm for reducing inductive coupling, and they are thin and flexible for 
enabling more stable mechanical positioning and easier manipulation of cables. 
The system is one-channel but scalable so it can be extended with more 
measurement channels. One channel requires one pair of cables and its 
electrodes can be positioned for both unipolar and bipolar measurements. There 
is also one DRL (Driven Right Leg) cable, included for additional reducing of 
capacitive coupling effect between respondent and environmental electrical 
installations. The name DRL is used because this is usual name for this 
technique since it was applied first time in electrocardiography measurements 
[16 – 17]. 
The amplifier, based on modular EEG design [18], is a three-stage 
amplifying and filtering circuit, implemented on one PCB (Printed Circuit 
Board). At the input, there is an electrostatic discharge protection circuit and 
passive low-pass filter for rejecting high frequencies (> 1 kHz). First amplifying 
stage is a preamplifier based on instrumentation amplifier INA114P for P. Sovilj, V. Ković, M. Biro, M. Radak, Z. Mitrović 
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obtaining high input impedance and high CMRR (Common Mode Rejection 
Ratio). From this stage, inverted common mode voltage is driven to the DRL 
output of the amplifier and further to DRL cable and location of subject. This 
technique is often used when it is necessary to increase CMRR, and in this 
amplifier’s CMRR is 102dB. 
 
Fig. 1 – Modular structure of the instrumentation system. 
 
Second amplifying stage has a central role for increasing the amplification 
gain. Also, before input and after output of this stage, there are high-pass filters 
with corner frequency of 0.15  Hz, thus providing rejection of offset voltage 
from amplifier input. Third stage has role of final amplification and also of anti-
aliasing filtering. The supply of the amplifier is unipolar (5 V), and there is also 
virtual ground buffered from 2  V voltage source. This voltage source is 
implemented on another PCB (the one with microcontroller) and leaded to the 
amplifier PCB. 
The role of digitizing block is digital measurement of the amplified voltage. 
This module is based on 8-bit microcontroller PIC18F4550 which has built-in 
A/D (analog-to-digital) converter with 10-bit resolution. Considering this 
resolution, the amplifier’s amplification gain and A/D conversion reference 
voltage, the effective input resolution of the system is 0.5 V.  
PIC18F4550 is an USB V2.0 compliant microcontroller. It has three power 
managed modes: run (CPU on, peripherals on), idle (CPU off, peripherals on) 
and sleep (CPU off, peripherals off). The microcontroller can operate at four 
crystal modes, including high precision PLL for USB (there are two external 
clock modes, up to 48 MHz). Internal oscillator block enables 8 user-selectable 
frequencies, from 31 kHz to 8 MHz, which are also user-tunable to compensate 
for frequency drift. Secondary oscillator can be used by timer 1 at 32 kHz. Dual 
oscillator options allow microcontroller and USB module to run at different 
clock speeds, and fail-safe clock monitor allows for safe shutdown if any clock 
stops[19]. 
The Analog-to-Digital (A/D) converter module of the microcontroller has 
13 inputs, and this module allows serial conversion of an analog input signal to 
a corresponding 10-bit digital number. The maximum recommended impedance 
for analog sources is 2.5 kΩ. The module has five registers [19]: Measurement of Event-related Potentials and Placebo 
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• A/D Result High Register (ADRESH), 
• A/D Result Low Register (ADRESL), 
• A/D Control Register 0 (ADCON0), 
• A/D Control Register 1 (ADCON1), 
• A/D Control Register 2 (ADCON2). 
 
Fig. 2 – ADCON2: Register for controlling the microcontroller’s A/D module [19]. 
 
START MAIN
Turn off comparators (register 
CMCON)
AD converter configuration (register 
ADCON1)
IO ports configuration (registers 
TRISA and TRISB)
Global interrupts configuration 
(registers RCON and INTCON)
Timer 0 configuration (registers 
T0CON, TMROL and TMR0H)
Timer 1 configuration (registri T1CON, 
PIE1, TMR1L and TMR1H)
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INTERRUPT
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The ADCON0 register, controls the operation of the A/D module, the 
ADCON1 register, configures the functions of the port pins, and the ADCON2 
register (Fig. 2) configures the A/D clock source, programmed acquisition time 
and justification. ADCON2 register is significant, because of time management 
requests for ERP acquisition. Roles of its configuration bits are explained 
subsequently[19]: 
In the implemented system, used microcontroller’s clock is 8  MHz, so 
period of TOSC = 0.125 μs is the basis for calculation if enough number of 
firmware instructions (NISR-INS) can be performed during interrupt service 
routine. 256  Hz is the most common sampling frequency for EEG (electro-
encephalography) signal acquisition, so duration of interrupt service routine TISR 
should be less than 3.9  ms. Therefore, maximum NISR-INS is 7778, allowing 
enough space inside interrupt service routine for implementing acquisitions, 
basic data processing, timers management and communication handling. 
At Fig. 3 block diagram of the implemented firmware is presented. Output 
of the amplifier is lead to pin AN0, which is the input for the microcontroller’s 
A/D module. Timer 0 is used for generating calibration signal, and timer 1 for 
performing acquisitions, basic data processing and communication handling. 
Chosen sampling frequency of A/D conversion is 256 Hz. RB0 pin is the output 
of PWM calibration signal, RB1 pin is the input for signal from reaction taster 
(which is controlled by respondent during specific cognitive tasks regarding 
recognition of stimuli), and RB5 is the controlling output intended for 
measurement by oscilloscope. 
 
Fig. 4 – PCB design of thermal stimuli module. Measurement of Event-related Potentials and Placebo 
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Fig. 5 – Control flow diagram of the main software unit. P. Sovilj, V. Ković, M. Biro, M. Radak, Z. Mitrović 
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Data are being sent to last block of the instrumentation system by UART 
protocol. Digital outputs of microcontroller (RC6/TX and RC7/RX ) are used 
for this digital communication. Before connecting these outputs to MAX232 
(digital chip for serial communication), there are digital optocouplers 
implemented for achieving necessary galvanic isolation of the system. 
In the last block from Fig. 1, PC is used for hosting software application 
which triggers appropriate stimuli to subject, acquire and process measured data 
which results in ERP records. PC monitor is used for presenting visual stimuli 
to subject, and earphones are used for presenting sound stimuli to subject. 
Except those usual functionalities of PC and PC monitor in ERP 
instrumentation, PC is also integrated with thermal stimuli module and software 
application is extended by software module for control and synchronization of 
the thermal stimuli module. 
The thermal stimuli module is based on thermal probe made of isolated 
resistors, and controlled by microcontroller PIC18F2550 and power transistor 
TIP31C. PCB design of the thermal stimuli module is presented at Fig. 4. 
All firmware units are developed by compiler MicroC Pro for PIC, and all 
software units are developed in Delphi7 development environment. Control 
flow diagram of the main software application unit is given at Fig. 5. 
3 Results 
In this section, at first, the results regarding testing of the instrumentation 
system during its development are presented. After that, the results of the 
placebo related experiments [15], performed by those instrumentation system, 
are summarized and commented.  
During the development of the instrumentation, various test scenarios were 
performed for verification of electrodes and cables, conditioning (amplifying 
and filtering) circuits (Fig.  6), digital measurement circuits, firmware and 
software. Thermal stimuli module’s probe is calibrated for achieving 44
0C 
which is considered as the temperature of pain threshold. 
After these verifications, the instrumentation is validated through various 
typical oddball paradigm experiments, for obtaining expected P300 responses. 
This experimental paradigm is a technique used in ERP research in which trains 
of stimuli that are usually auditory or visual are used to assess the neural 
reactions to unpredictable but recognizable events. In measurement session 
setup (Fig.  7a), main electrode was connected to subject’s CZ and referent 
electrode to mastoid bone. The subject was asked to react by button pressing 
incidences of target stimuli that are hidden as rare occurrences (deviant stimuli) 
amongst a series of more common stimuli (standard stimuli). At Fig. 7b, some 
of averaged latencies of ERP P300 components, obtained during these 
experiments, are presented. Measurement of Event-related Potentials and Placebo 
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Fig. 6 – Testing of an amplifying PCB during development of instrumentation. 
 
(a)                                                                           (b) 
Fig. 7 – (a) Measurement session setup; (b) Measured ERP P300 latencies. 
 
In the last phase, the instrumentation is applied in placebo related 
experiments. In those experiments, the design of experiments enabled relations 
between measured parameters and placebo effects.  
Experimental results for one respondent are shown at Fig. 8, and experimental 
oddball paradigm was followed. Vertical axe show ERP voltage in microseconds 
and horizontal axis show time in milliseconds. Green line is the average of standard 
epochs, and red line is the average of deviant epochs. In this experiment total 
number of epochs is 100, and total number of deviant epochs is 20. P. Sovilj, V. Ković, M. Biro, M. Radak, Z. Mitrović 
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Fig. 8 – Waveforms of acquainted and processed epoch samples. Red line waveform is 
calculated from samples acquainted during deviant stimuli presentation, and green line 
waveform is calculated from samples acquainted during standard stimuli presentation. 
 
Deviant stimuli were pseudo randomly presented by the algorithm based on 
Delphi built-in random functions and additional limitation of avoiding 
subsequential deviant stimuli. Moreover, there were at least two standard 
stimuli between subsequential deviant stimuli. This limitation was implemented 
for avoiding subject’s expectations, which are supposed to be greater if there is 
no this limitation. Results were being saved into file system as CSV(comma 
separated values) files, but also graphically presented by the application. 
Details on the design of these experiments, and details on findings of those 
placebo effect researches are presented in [15]. In the next paragraphs of this 
section we comment the main findings of those researches. 
The first and foremost conclusion in [15] is that distinct neural correlates of 
analgesia/expectancy based on the different profiles of the ERP waveforms are 
registered. All three experimental situations with analgesia showed different 
ERP early effects in comparison to the condition with no analgesia. This result 
is also correspondent with the subjective judgment of the respondents. 
Interestingly, the results showed the placebo effect does not differ from the 
pharmaco-analgesia. These results are interpreted as early expectancies that any 
analgesic should produce some effect in comparison to no-analgesic condition. 
In the subjective judgment data effects of “anti-placebo” were not 
observed. However, in the medium ERP effects prominently distinct "anti-
placebo" and no-analgesia effects in comparison to the analgesia and placebo Measurement of Event-related Potentials and Placebo 
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effects were observed. However, neural correlates, or their unconsciousness 
responses revealed that the duration of the effects in the absence of analgesia 
and in the anti-placebo situation are identical. This result led the authors of [15] 
to the conclusion, that on the neural level, suggestion of “bad medicament” 
(similar to situation of no-medicament) caused such a metal activity which, 
figuratively, can be interpreted as a worry-response – “is this still going to hurt 
me?” This effect is the one which calls into a question doctors’ recommendations 
(which contain negative connotation) of medicaments, as they could potentially 
and unconsciously diminish a valuable impact that the placebo could have 
during a treatment. 
4 Conclusion 
Contemporary studies of placebo are often based on functional neuro-
magnetic resonance (fMRI), positron emission tomography (PET), and event 
related potentials (ERP). Following those studies, experiments related to 
researching placebo by measurements of ERP, were performed in Laboratory of 
experimental psychology Novi Sad.  
This paper considers a novel ERP instrumentation system used in those 
experiments, and gives the results of testing the instrumentation system during 
development, and comments the results of applying the instrumentation system 
in [15]. To best knowledge of the authors, this is the first one-PC based ERP 
instrumentation system designed for ERP/placebo experiments, and the first 
ERP instrumentation system with thermal stimuli module integrated with PC. 
The instrumentation system can be divided into four modules: electrodes 
and cables, conditioning module, digital measurement module, and PC module 
for presentations, acquisition and data processing. The system is one-channel 
but scalable so it can be extended with more measurement channels. 
Considering A/D converter’s resolution, the amplifier’s amplification gain and 
A/D conversion reference voltage, the effective input resolution of the system is 
0.5 V. Chosen sampling frequency of A/D conversion is 256 Hz. 
PC is used for hosting software application which triggers appropriate 
stimuli to subject, acquire and process measured data which results in ERP 
records. PC monitor is used for presenting visual stimuli to subject, and 
earphones are used for presenting sound stimuli to subject. Except those usual 
roles of PC in ERP instrumentation, PC is also integrated with thermal stimuli 
module and software application is extended by software module for control 
and synchronization of the thermal stimuli module. 
It is important to emphasize the researches from [15], because they are the 
application of the presented instrumentation system, and those researches and 
the instrumentation system together are an example of successful interdiscipli-
nary effort which lead to the novelties in two directions – development of new P. Sovilj, V. Ković, M. Biro, M. Radak, Z. Mitrović 
312 
instrumentation system and new insights into placebo effects. Researches from 
[15]: 1) gave a new confirmation of correlation between ERP and placebo, and 
2) opened a new and interesting area of studying correlation between ERP and 
anti-placebo effects. 
For these experimental researches purpose, in the instrumentation system 
oddball paradigm model is applied, for obtaining expected P300 responses. The 
oddball paradigm is a technique used in ERP research in which trains of stimuli 
that are usually auditory or visual are used to assess the neural reactions to 
unpredictable but recognizable events. In measurement session setup, main 
electrode was connected to subject’s CZ and referent electrode to mastoid bone. 
The subject was asked to react by button pressing incidences of target stimuli 
that are hidden as rare occurrences (deviant stimuli) amongst a series of more 
common stimuli (standard stimuli). 
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